Sort
82,697 grants matching “vaccine development”
Universal Influenza Vaccine Development
$2,153,677Jeffery Taubenberger · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Oklahoma Center for Microbial Pathogenesis and Immunity
$2,153,497Jimmy D. Ballard · University Of Oklahoma Hlth Sciences Ctr · P20 · FY2025 · GM
SPORE in Lymphoma
$2,153,287Helen E Heslop · Baylor College Of Medicine · P50 · FY2011 · CA
Core B: Virology Core
$2,153,145Ralph S Baric · University Of Washington · P01 · FY2022 · AI
SPORE in Cervical Cancer
$2,152,942T.-C. Wu · Johns Hopkins University · P50 · FY2016 · CA
CD40L-Adjuvanted Vaccines for HIV/AIDS
$2,152,839Rama Rao Amara · Emory University · P01 · FY2013 · AI
IMMUNE MECHANISMS CONTROLLING INFLAMMATION AND CANCER
$2,152,722Dartmouth College · P20 · FY2005 · RR
Environmental/genetic Risk Factors and Pathogenesis of Autoimmune Disease
$2,152,098Frederick Miller · National Institute Of Environmental Health Sciences · ZIA · FY2018 · ES
Columbia Partnership for Prevention and Control of HIV/AIDS Clinical Trials Unit
$2,150,863Scott M Hammer · Columbia University Health Sciences · UM1 · FY2017 · AI
Seattle Cancer Consortium Breast SPORE
$2,150,779Peggy L Porter · Fred Hutchinson Cancer Research Center · P50 · FY2014 · CA
SPORE in Gastrointestinal Cancer
$2,150,501Scott E Kern · Johns Hopkins University · P50 · FY2013 · CA
SPORE in Cervical Cancer
$2,150,500T.-C. Wu · Johns Hopkins University · P50 · FY2013 · CA
SPORE in Skin Cancer
$2,150,500John Munn Kirkwood · University Of Pittsburgh At Pittsburgh · P50 · FY2013 · CA
Specialized Program of Research Excellence
$2,150,500Jennifer R Grandis · University Of Pittsburgh At Pittsburgh · P50 · FY2013 · CA
M. D. Anderson Cancer Center SPORE in Multiple Myeloma
$2,150,500Robert Zygmunt Orlowski · University Of Tx Md Anderson Can Ctr · P50 · FY2013 · CA
RPCI-UPCI Ovarian Cancer SPORE
$2,150,500Kunle O Odunsi · Roswell Park Cancer Institute Corp · P50 · FY2013 · CA
SPORE in Lymphoma
$2,150,500Helen E Heslop · Baylor College Of Medicine · P50 · FY2013 · CA
Mayo Clinic SPORE in Ovarian Cancer
$2,150,500Scott H Kaufmann · Mayo Clinic Rochester · P50 · FY2013 · CA
SPORE University of Texas M.D. Anderson Cancer Center SPORE-Leukemia
$2,150,500Hagop Kantarjian · University Of Tx Md Anderson Can Ctr · P50 · FY2013 · CA
Pacific Ovarian Cancer Research Consortium
$2,150,499Charles Drescher · Fred Hutchinson Cancer Research Center · P50 · FY2013 · CA
Targeted antigen receptor treatment of cancer
$2,150,453Alan N. Houghton · Sloan-Kettering Inst Can Research · P01 · FY2007 · CA
Therapy, Vaccine and Model Development in Viral Hepatitis and Liver Diseases
$2,150,109T. Jake Liang · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2025 · DK
Development And Production Of A Multiclade HIV-1 DNA Plasmid Vaccine
$2,149,913Richard Schwartz · National Institute Of Allergy And Infectious Diseases · ZIB · FY2012 · AI
Development Of A Multicomponent HIV-1 Recombinant Adenoviral Vector Vaccine
$2,149,913Richard Schwartz · National Institute Of Allergy And Infectious Diseases · ZIB · FY2012 · AI
Small molecule stimulators for use as adjuvants for antiviral vaccines
$2,149,625Michael J Gale · University Of Washington · N01 · FY2011 · AI